That is essential, because the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be effective. To put it simply, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (future report review). But now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. This was a breakthrough practically nobody discovered. But it's going to have profound implications for curing illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of financial investment opportunities in this space, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech pick). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back possibly substantially before going higher - legacy report prediction. I've been covering bitcoin for a long period of time now. Among the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. But that's not the big concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. jeff brown genetic sequencer stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous great private companies on the edge of striking the public markets And I've been dealing with a new method for you to invest even before these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to reserve your spot totally free.
Emma Walsh here, managing editor of the Diary. Routine Journal readers understand that tech isn't our normal beat (the legacy report prediction). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we know (jeff brown investor prediction). In reality, he had a number of triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These trends are experiencing exponential development and developing extraordinary opportunities for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. jeff brown investor prediction. But despite what many readers may believe, this is a pattern that's simply beginning. Although the COVID-19 pandemic disrupted supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (first lady). Losing 2 months of production and sales truly affects how many 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million systems is impressive. More importantly, the hold-ups brought on by the pandemic produced a lot of bottled-up demand. Which demand is now going to be pushed into 2021. In fact, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - black sea. Which's not my only 5G prediction When I've discussed 5G in the past, I have actually described its 3 various phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Stage 3, 5G services begin to be provided (tech stocks). That's when we begin to see applications operating on 5G networks. Consider things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage Three by this summertime. This begins something of a virtuous cycle: Many people do not actually care about the innovation. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open a suite of incredible applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The investment chances going forward will be huge. Stepping far from 5G, the next important innovation I foresee in 2021 is CRISPR genetic editing. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a similar idea however with our genetic code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And throughout that time, there were actually only 3 companies operating in this space. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating illness and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing amazing returns. This whole market is successfully a greenfield opportunity.
There's room for lots of business to exist in this space. jeff brown genetic sequencer stock. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or three more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software can accurately predict the folding of a protein based solely on its amino acid series with 92. 4% precision. That is necessary since the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental procedure. And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced using this technology. This was among those developments that practically no one discovered. But it's going to have extensive implications for curing illness. And, of course, there will be plenty of investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe significantly prior to going higher. I've been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin - what is the legacy report predicting. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. However at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. future report review. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date since February 2021, however we might not independently validate this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this minute. Brown is best known for his sage-like capability to select winning technology stocks. He spent more than 25 years investigating technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding viewpoint on the marketplace. He's always on the hunt for brand-new chances, and he shares a lot of his best picks in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he successfully forecasted some of the biggest economic events of the past twenty years. Although he does not appear to launch his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it best each time, but Jeff Brown's precise predictions have actually earned him legions of dedicated fans. That states a lot about his ability. The Future Report is released by Brownstone Research study, a popular monetary research study publisher. Brownstone Research study uses a number of research services with a wide variety of expertises - jeff brown biotech stocks.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - brownstone research stock. On its website, Brownstone states its mission is to provide retail investors with professional-grade research: "For too long, the finest financial investment research has actually not been available to individual investors. It has actually been normally scheduled for investment banks, hedge funds, private equity, and high-net-worth customers. tech stock. The objective of Brownstone Research is to make that sort of exclusive research offered to any investors looking to acquire an edge in the markets. The goal is basic to provide distinct and profitable financial investment research found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the company's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After decades of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you know even a bit about the market, you know that he has a reputation as a King Midas of sorts. brownstone research. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In fact, Brown thinks S.A.V. jeff brown biotech stock. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying 2 innovative innovations: synthetic intelligence and electrical vehicles. Musk hopes the combination will help him develop the first fully-autonomous, self-driving vehicles ever. It's nothing brief of the automobile industry's Holy Grail. As you understand, electric vehicles and self-driving cars and truck stocks have actually been big this year, but the Wall Street maker has been huge on buzz without much tangible result. In spite of a drastic boost in competition over the previous few years, Brown still believes Musk has the very best opportunity of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transport. Essentially, this technology would enable you to rent out your vehicle as a self-governing, self-driving taxi when you're not using it. You just get out of the automobile and press a button on an app that informs the car to "join the fleet." Next thing you know, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the profits. It sounds insane, but it could be closed than you believe.